作者：
Kumar,S. [1]
;
Flinn,I. [2]
;
Richardson,P.G. [3]
;
Hari,P. [4]
;
Callander,N. [5]
;
Noga,S.J. [6]
;
Stewart,A.K. [7]
;
Turturro,F. [8]
;
Rifkin,R. [9]
;
Wolf,J. [10]
;
Estevam,J. [11]
;
Mulligan,G. ;
Shi,H. ;
Webb,I.J. ;
Rajkumar,S.V.
作者单位：
Sinai Hospital of Baltimore, Baltimore, MD, United States
[1]
Bone Marrow/Hematology Clinics, University of Wisconsin Comprehensive Cancer Center, Madison, WI
[2]
Sarah Cannon Research Institute, Nashville, TN, United States
[3]
Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States
[4]
Department of Medicine, Feist-Weiller Cancer Center, Louisiana State University Health Sciences
[5]
Rocky Mountain Cancer Centers, Denver, CO, United States
[6]
Department of Medical Oncology Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
[7]
Millennium Pharmaceuticals Inc., Cambridge, MA, United States
[8]
Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States
[9]
Clinical Research, University of California San Francisco, San Francisco, CA, United States
[10]
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States
[11]
发布时间
2013-11-20
换一批
